Exploring Athersys Stroke Program
Exploring Athersys Stroke Program reveals several interesting facts.
- Athersys
- Gil Van Bokkelen, Ph.D., Chairman & CEO Cleveland, OH (NASDAQ:
- Robert Mays, Ph.D., VP of Regenerative Medicine and Head of Neuroscience Cleveland, OH (NASDAQ:
- Gil Van Bokkelen, Ph.D., Chairman and CEO Cleveland, OH (NASDAQ:
- Athersys
In-Depth Information on Athersys Stroke Program
Dr. Robert (Willie) Mays discusses the Dr. Sarah Busch gives an overview of the exciting preclinical research being conducted by Clip courtesy of Fox32 in Chicago. Athersys stroke animation MultiStem MoA
Gil Van Bokkelen, Ph.D., Chairman & CEO (NASDAQ:
Stay tuned for more updates related to Athersys Stroke Program.